These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Polymer-based microparticles in tissue engineering and regenerative medicine. Oliveira MB; Mano JF Biotechnol Prog; 2011 Jul; 27(4):897-912. PubMed ID: 21584949 [TBL] [Abstract][Full Text] [Related]
64. Nanomaterials for in situ cell delivery and tissue regeneration. Wan AC; Ying JY Adv Drug Deliv Rev; 2010 Jun; 62(7-8):731-40. PubMed ID: 20156499 [TBL] [Abstract][Full Text] [Related]
65. Regenerative medicine: Materials in a cellular world. Hunt JA Nat Mater; 2008 Aug; 7(8):617-8. PubMed ID: 18654587 [No Abstract] [Full Text] [Related]
66. [The current status and future perspective of tissue engineering and regenerative medicine]. Yamato M Nihon Rinsho; 2011 Dec; 69(12):2098-101. PubMed ID: 22242304 [No Abstract] [Full Text] [Related]
67. Tracheobronchial bio-engineering: biotechnology fulfilling unmet medical needs. Walles T Adv Drug Deliv Rev; 2011 Apr; 63(4-5):367-74. PubMed ID: 21295094 [TBL] [Abstract][Full Text] [Related]
69. In vitro, in vivo, in silico: computational systems in tissue engineering and regenerative medicine. Semple JL; Woolridge N; Lumsden CJ Tissue Eng; 2005; 11(3-4):341-56. PubMed ID: 15869415 [TBL] [Abstract][Full Text] [Related]
72. Application of 3D biomimetic models in drug delivery and regenerative medicine. Xu Y; Wang X Curr Pharm Des; 2015; 21(12):1618-26. PubMed ID: 25594404 [TBL] [Abstract][Full Text] [Related]
73. Isolation of smooth muscle cells from bladder for generation of engineered urologic organs. McCoy DW Methods Mol Biol; 2013; 1001():13-20. PubMed ID: 23494416 [TBL] [Abstract][Full Text] [Related]
74. Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010. Mason C; Manzotti E Regen Med; 2010 May; 5(3):307-13. PubMed ID: 20455641 [No Abstract] [Full Text] [Related]
75. The first stem cell-based tissue-engineered organ replacement: implications for regenerative medicine and society. Hollander A; Macchiarini P; Gordijn B; Birchall M Regen Med; 2009 Mar; 4(2):147-8. PubMed ID: 19317632 [No Abstract] [Full Text] [Related]
76. Implementing tissue engineering and regenerative medicine solutions in medical implants. Ye D; Peramo A Br Med Bull; 2014; 109():3-18. PubMed ID: 24357734 [TBL] [Abstract][Full Text] [Related]
78. Design of self-assembling peptides and their biomedical applications. Liu J; Zhao X Nanomedicine (Lond); 2011 Nov; 6(9):1621-43. PubMed ID: 22077465 [TBL] [Abstract][Full Text] [Related]
79. Meeting the needs of monitoring in tissue engineering. Mather ML; Morgan SP; Crowe JA Regen Med; 2007 Mar; 2(2):145-60. PubMed ID: 17465747 [TBL] [Abstract][Full Text] [Related]
80. From kidney development to drug delivery and tissue engineering strategies in renal regenerative medicine. Dankers PY; Boomker JM; Meijer EW; Popa ER; van Luyn MJ J Control Release; 2011 May; 152(1):177-85. PubMed ID: 21334390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]